关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nicpbp.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  4 9 5 0 9 8 9 位浏览者
您当前的位置:首页 >> 正文

多肽微球缓释注射剂中载体辅料丙交酯乙交酯共聚物的关键质量属性分析

Analysis of the critical quality attributes of poly(lactide-co-glycolide)in polypeptide microsphere sustained release injection

分类号:R917
出版年·卷·期(页码):2020,40 (6):988-998
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的: 对部分已上市多肽微球注射剂中丙交酯乙交酯共聚物(PLGA)的关键质量属性进行表征和分析,为全面评价该类制剂及其体外释放度加速试验方法研究提供参考。方法: 采用凝胶渗透色谱法(GPC)、核磁共振谱法(1H NMR)、GPC三联检测器法(GPC-3D)和差示扫描量热分析仪法(DSC),分别测定多肽微球注射剂和多种丙交酯乙交酯共聚物样品的相对重均分子质量(MwR)、丙交酯乙交酯摩尔比(L:G)与微球中PLGA含量、绝对重均分子质量(MwA)与支化度(g')、玻璃化转变温度(Tg),分析影响微球注射剂Tg的因素。结果: 5种12个不同规格的多肽微球注射剂中PLGA的MwR在12~53 kDa;L:G值有52:48、50:50、53:47、55:45、74:26、75:25和100:0;PLGA含量在55.8%~80.5%;MwMwAR在7~45 kDa,线型载体微球的g'值为0.9~1.0,星型载体微球的G值在0.8左右;Tg值在32.1~47.2℃。11种型号的纯PLGA样品的MwR在23~70 kDa;L:G值有50:50、55:45和60:40;MwMwAR在1.5~6.1万道尔顿,线型PLGA的g'值在0.9~1.0,非线型PLGA的g'值随着其结构在0.6~0.8之间变化;Tg值在35.5~44.5℃。结论: 多肽微球注射剂中丙交酯乙交酯共聚物的相对分子质量、L:G值及含量对Tg值的影响呈正相关,且其支化度对Tg值也有一定的影响。本文可为多肽微球缓释注射剂丙交酯乙交酯共聚物的表征及其内在质量的对比研究,以及体外释放度加速试验方法的研究提供参考。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: The critical quality attributes of poly (lactide-co-glycolide)(PLGA) in some polypeptide microsphere injection on the market were characterized and analyzed,which provides a reference for the comprehensive evaluation of both the kind of formulation and the research of the in vitro accelerated release test methods. Methods: The methods of gel permeation chromatography (GPC),magnetic resonance spectroscopy (1H NMR),GPC triple detector (GPC-3D),and differential scanning calorimetry (DSC) were respectively used to determine the relative weight average molecular weight (MwR),the molar ratio of lactide to glycolide (L:G),the content of poly(lactide-co-glycolide)(PLGA) in microsphers,the absolute weight average molecular weight(MwMwAR)and branching degree (g'),the glass transition temperature (Tg) of polypeptide microsphere injections and various PLGA samples. And the factors influencing the Tg of microsphere injections were analyzed. Results: The MwR of PLGA in 5 kinds of 12 different specifications of polypeptide microsphere injections were 12-53 kDa;There were 7 kinds of L:G with the ratio value of 52:48,50:50,53:47,55:45,74:26,75:25 and 100:0,respectively;The content of PLGA was 55.8%-80.5%;The MwMwAR were 7-45 kDa,the g' value of linear carrier microspheres was 0.9-1.0,and that of star carrier microspheres was around 0.8. The Tg was 32.1-47.2℃. The MwR of 11 kinds of pure PLGA samples were 23-70 kDa;There were 3 kinds of L:G with the ratio value of 50:50,55:45 and 60:40,respectively;The MwMwAR were 15-61 kDa,the g' value of linear PLGA was 0.9-1.0,and the g' value of non-linear PLGA varies with its structure from 0.6 to 0.8;The Tg was 32.1-47.2℃. Conclusions: The molecular weight,L:G value and content of PLGA in polypeptide microsphere injections had a positive correlation with its Tg value,and its branching degree also has some influence on the Tg. This paper can provide a reference for the comprehensive characterization of polypeptide microsphere injection and the comparative study of their internal quality,as well as the study of the in vitro accelerated release test method.

-----参考文献:---------------------------------------------------------------------------------------

[1] 王玉静,孙秀芝,徐丽,等.微球制剂的研究进展及前景分析[J].生物化工,2017(2):80 WANG YJ,SUN XZ,XU L,et al.Research progress and prospect analysis of microsphere formulations[J].Biochemistry,2017(2):80
[2] 何广宏,万丹丹,董然.长效微球注射剂的研究进展[J].中国医院药学杂志,2015,35(10):963 HE GH,WAN DD,DONG R.Research progress of long-acting microsphere injection[J].Chin J Hosp Pharm,2015,35(10):963
[3] 李勋,韦祎,马光辉,等.缓释微球制剂的研究进展[J].北京化工大学学报(自然科学版),2017,44(6):1 LI X,WEI Y,MA GH,et al.Research progress of sustained release microsphere formulations[J].J Beijing Univ Chem Technol (Nat Sci Edit),2017,44(6):1
[4] GUO NZ,ZHANG Q,SUN Y,et al.Separation and identification of acylated leuprorelin inside PLGA microspheres[J].Intern J Pharm,2019,560:273
[5] JOHN G,SARAH S,HAESUN P,et al.A protocol for assay of poly(lactide-co-glycolide) in clinical products[J].Int J Pharm,2015,495(1):87
[6] ZHANG Q,GUO NZ,SUN Y,et al.Absolute quantification of poly (dl-lactide-co-glycolide) in microspheres using quantitative 1H NMR spectroscopy[J].J Pharm Biomed Anal,2017,146:273
[7] HADAR J,SKIDMORE S,GARNER J,et al.Characterization of branched poly(lactide-co-glycolide) polymers used in injectable,long-acting formulations[J].J Controlled Rel,2019,304:75
[8] 王洪亮,汪仁芸,刘玉玲.胸腺五肽长效微球玻璃化温度测定及释放度加速试验方法的研究[C].2006年全国生化与生物技术药物学术年会论文集,2006:257 WANG HL,WANG RY,LIU YL.Determination of Glass Transition Temperature and Study of Accelerated Release Test Method of Thymopentin Long-acting Microspheres[C].Proceedings of 2006 National biochemical and biotechnology pharmaceutical academic annual conference,2006:257
[9] 徐颖,张勇.测量玻璃化转变温度的几种热分析技术[J].分析儀器,2010(3):57 XU Y,ZHANG Y.Several thermal analysis techniques for measuring glass transition temperature[J].Anal Instrum,2010(3):57
[10] HADAR J,SKIDMORE S,GARNER J,et al.Method matters:Development of characterization techniques for branched and glucose-poly (lactide-co-glycolide) polymers[J].J Controlled Rel,2020,320:484
[11] PARK K,SKIDMORE S,HADAR J,et al.Injectable,long-acting PLGA formulations:Analyzing PLGA and understanding microparticle formation[J].J Controlled Rel,2019,304:125
[12] 卢新亚,姜炳政.高聚物玻璃化转变温度和分子参数的关系I.高聚物链柔性与Tg的关系[J].高分子学报,1990,1(4):434 LU XY,JIANG BZ.Relationship between glass transition temperature and molecular parameters of polymers Ⅰ.The relationship between polymer chain flexibility and Tg[J].J Polym Sci,1990,1(4):434
[13] OMELCZUK MO,McGINITY JW.The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly (DL-lactic acid)[J].Pharm Res,1992,9(1):26
[14] 张伊洁,郭宁子,刘万卉,等.缓控释注射剂中丙交酯乙交酯共聚物(PLGA)分析方法的研究进展[J].中国医药工业杂志,2019,50(10):1180 ZHANG YJ,GUO NZ,LIU WH,et al.Research in analytical methods of poly(lactide-co-glycolide) (PLGA) in sustained and controlled release for injections[J].Chin J Pharm Ind,2019,50(10):1180
[15] STEENDAM R,VAN SM,HENNINK W,et al.Effect of molecular weight and glass transition on relaxation and release behaviour of poly (DL-lactic acid) tablets[J].J Controlled Rel,2001,70(1-2):71
[16] KAPOOR DN,BHATIA A,KAUR R,et al.PLGA:a unique polymer for drug delivery[J].Therap Deliv,2015,6(1):41
[17] TOMIC I,VIDIS MA,MUELLER ZM,et al.Setting accelerated dissolution test for PLGA microspheres containing peptide,investigation of critical parameters affecting drug release rate and mechanism[J].Intern J Pharm,2016,505(1-2):42
[18] ZOLNIK BS,LEARY PE,BURGESS DJ.Elevated temperature accelerated release testing of PLGA microspheres[J].J Controlled Rel,2006,112(3):293

欢迎阅读《药物分析杂志》!您是该文第 107位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn

本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838